Oculus up 19% in early trading

|About: Oculus Innovative Scie... (OCLS)|By:, SA News Editor

Shares of nano cap Oculus Innovative Sciences (OCLS +19.7%) enjoy a pop this morning continuing the up move that began on December 4 when the firm reported the FDA clearance of Microsyn Scar Management HydroGel.

Consensus estimate for Q1 is a loss of $0.19/share on revenues of $3.4M.

Consensus estimates for 2014 and 2015 are a loss of $0.51/share on revenues of $14.2M and a loss of $0.48/share on revenues of $15.2M, respectively.

10 mutual funds have positions, up from 9 a year earlier.